GT Biopharma, Inc.GTBPNASDAQ
Loading
Shares Out (Diluted) Over TimeContracting
Percentile Rank86
3Y CAGR-44.3%
5Y CAGR+4.7%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
-44.3%/yr
vs +81.2%/yr prior
5Y CAGR
+4.7%/yr
Recent deceleration
Acceleration
-125.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5513255.00 | +190.6% |
| 2024 | 1897000.00 | +40.7% |
| 2023 | 1348000.00 | -95.8% |
| 2022 | 31868000.00 | +13.2% |
| 2021 | 28155624.00 | +542.1% |
| 2020 | 4385000.00 | +29.5% |
| 2019 | 3385000.00 | +14.6% |
| 2018 | 2955000.00 | +199.6% |
| 2017 | 986419.00 | +617726.6% |
| 2016 | 159.66 | - |